Editorial: Mechanisms of Novel Drugs and Gene Modifiers in the Treatment of Cystic Fibrosis
Front Mol Biosci
.
2022 Jul 12:9:975946.
doi: 10.3389/fmolb.2022.975946.
eCollection 2022.
Authors
Guido Veit
1
,
Iris Silva
2
,
Massimo Conese
3
,
Onofrio Laselva
3
Affiliations
1
Department of Physiology, McGill University, Montréal, QC, Canada.
2
S2AQUAcoLAB, Olhao, Portugal.
3
Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
PMID:
35903150
PMCID:
PMC9315944
DOI:
10.3389/fmolb.2022.975946
No abstract available
Keywords:
CFTR; CFTR corrector; IGFBP-6; SLC6A14; cystic fibrosis.
Publication types
Editorial